Stocks That Hit 52-Week Lows On Monday
Portfolio Pulse from Benzinga Insights
On Monday, 85 stocks hit new 52-week lows, with Bristol-Myers Squibb being the biggest company on a market cap basis to set a new low. Adamis Pharmaceuticals was the biggest loser, trading down 6320.0%, while Greystone Housing Impact shares were the most resilient, rising 0.0%.
May 22, 2023 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adamis Pharmaceuticals (NASDAQ:ADMP) was the biggest loser, trading down 6320.0% to reach its 52-week low of $3.10.
Adamis Pharmaceuticals being the biggest loser and hitting a new 52-week low indicates a strong bearish sentiment in the market for the stock. This could lead to further downward pressure on the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Bristol-Myers Squibb (NYSE:BMY) hit a new 52-week low of $65.14 on Monday, down 0.52%.
Bristol-Myers Squibb hitting a new 52-week low indicates a bearish sentiment in the market for the stock. This could lead to further downward pressure on the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEUTRAL IMPACT
Greystone Housing Impact (NYSE:GHI) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low of $15.28.
Greystone Housing Impact shares being the most resilient and rebounding from its new 52-week low indicates a neutral sentiment in the market for the stock. This could lead to a stable stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100